Computer Model Challenges Breast Cancer Treatment Strategy
- 1 January 1994
- journal article
- research article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 12 (6) , 559-567
- https://doi.org/10.3109/07357909409023040
Abstract
The breast cancer treatment failure rate remains unacceptably high. The current breast cancer treatment paradigm, based primarily on Gompertzian kinetics and animal models, advocates short-course, intensive chemotherapy subsequent to tumor debulking, citing drug resistance and host toxicity as the primary reasons for treatment failure. To better understand treatment failure, we have studied breast cancer from the perspective of computer modeling. Our results demonstrate breast cancers grow in an irregular fashion; this differs from the Gompertzian mode of animal models and thus challenges the validity of the current paradigm. Clinical and laboratory data support the concept of irregular growth rather than the common claim that human tumors grow in a Gompertzian fashion. Treatment failure mechanisms for breast cancer appear to differ from those for animal models, and thus treatments optimize on animal models may not be optimal for breast cancer. A failure mechanism consistent with our results involves temporarily dormant tumor cells in anatomical or pharmacological sanctuary, which eventually result in aggressive metastatic disease.Keywords
This publication has 18 references indexed in Scilit:
- Saltation and Stasis: a Model of Human GrowthScience, 1992
- Breast carcinoma growth rate described by mammographic doubling time and S-phase fraction. Correlations to clinical and histopathologic factors in a screened populationCancer, 1992
- Is Gompertzian or exponential kinetics a valid description of individual human cancer growth?Medical Hypotheses, 1990
- Dormancy and breast cancerJournal of Surgical Oncology, 1990
- Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow CytometryNew England Journal of Medicine, 1989
- DNA ploidy and survival in breast cancer patientsCytometry, 1987
- The human tumor clonogenic assay in human breast cancer.Journal of Clinical Oncology, 1985
- The james ewing lecture. The relationship between tumor mass and resistance to chemotherapy. Implications for surgical adjuvant treatment of cancerCancer, 1983
- Growth Rate Patterns of Solid Tumors and Their Relation to Responsiveness to TherapyAnnals of Internal Medicine, 1978
- Kinetics of mammary tumor cell growth and implications for therapyCancer, 1971